Novartis Vaccines and Diagnostics - Region North America re-org

Discussion in 'Novartis' started by Anonymous, Jan 4, 2012 at 4:57 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    All properties in Cambridge are leased through 2019 the deal was done last fall. All property goes with GSK
     

  2. Anonymous

    Anonymous Guest


    That lease also includes RTP since it is the same Co. but i think that is 2017
     
  3. Anonymous

    Anonymous Guest

    Sub-leased to GSK, not transfered. Novartis will ultimately eat the cost if they don't have someone sub-leasing from them, or decide to bump out NIBR even further. There is a NIBR office directly across from 75 Sidney now, brand new and newly renovated. 64 Sidney I heard.
     
  4. Anonymous

    Anonymous Guest

    A few years ago, folks in Vaccines technical development were interested in leasing a floor in 64 Sidney St to expand laboratories from 45 Sidney St. That was put on hold when the Holly Springs pilot plant was approved and eventually the all work and all the Cambridge based people were asked to move to NC. Very few did move, and I am sure they all regret that decision.
     
  5. Anonymous

    Anonymous Guest

    Yes, clearly NVx staff transferring to GSK have nothing to worry about.

    If you've been hanging on for severance and accelerated vesting, then Feb. 2 is your lucky day, and your payout is right around the corner. But Kool-Aid drinkers beware! Any of you singing the hopes and promise of a new future and longlasting career under GSK leadership are plain stupid!! Can't say you weren't warned. Go back and read posts on this site from six months ago (and I love how management dismisses this as nothing more than a gossip site with no credibility whatsoever).

    On the bright side, we don't have to pretend anymore. All of these really important projects that people have been breaking their backs to complete because of some perceived urgency can now coast into oblivion. Even better... With 2014 practically over now, we don't have to listen to AO and his executive parrots talk about staying focused and delivering on 2014 objectives any longer. Now that is a year-end bonus in and of itself!
     
  6. Anonymous

    Anonymous Guest

    What is going on in Florida? New management? Again?
     
  7. Anonymous

    Anonymous Guest

    I posted this last year!! Post 1116. I am the god of knowledge. You can trust anything I post here. Novartis is a garbage company to work for.
     
  8. Anonymous

    Anonymous Guest

    vaccines has no leadership
     
  9. Anonymous

    Anonymous Guest

    no leadership, no leaders, no products, a lost cause....
     
  10. Anonymous

    Anonymous Guest

    March 2md 12000 Novartis join GSK

    !000 in Support Services ie HR / Finance / Legal

    How many from each of Consumer and Vaccines?
     
  11. Anonymous

    Anonymous Guest

    All G&A, support services will be given severance on 3/02/15. Research will be reviewed and reduced by 60-75% by Q3. Be prepared!
     
  12. Anonymous

    Anonymous Guest

    What about NA Sales and all of Tech Ops?
     
  13. Anonymous

    Anonymous Guest

    GSK won't take most of NA sales.
     
  14. Anonymous

    Anonymous Guest

    "....more than 40, less than 100...."
     
  15. Anonymous

    Anonymous Guest

    So, is the deal closing February 1 or March 1?
     
  16. Anonymous

    Anonymous Guest

    Yes, it will.
     
  17. Anonymous

    Anonymous Guest

    Which one?